Biotechnology Report
: Analysis on the Market, Trends, and TechnologiesThe biotechnology market is entering an accelerated growth phase, underpinned by a 24.31% annual rise in funding rounds over the past year and a projected expansion from USD 483.0 billion in 2024 to USD 546.0 billion by 2025 at a 13.0% CAGR Global Biotechnology Market Outlook 2025: Driving Growth at 13.0% CAGR. This surge reflects intensifying R&D activity in areas such as gene therapies and computational biology, alongside mounting demand for biologic drugs, sustainable agricultural solutions, and industrial bioprocesses.
This report was last updated 37 days ago. Spot an error or missing detail? Help us fix it by getting in touch!
Topic Dominance Index of Biotechnology
To identify the Dominance Index of Biotechnology in the Trend and Technology ecosystem, we look at 3 different time series: the timeline of published articles, founded companies, and global search.
Key Activities and Applications
- Development of biologic therapeutics—including monoclonal antibodies and gene therapies targeting cancer and genetic disorders—to meet rising demand for advanced treatments Biotechnology Market Trends & YoY Growth Rate, 2025-2032
- Expansion of diagnostic platforms for early detection of chronic diseases (cancer, diabetes, cardiovascular and respiratory conditions) via molecular assays and point-of-care testing Global Biotechnology Market 2022-2028
- Agricultural biotechnology applications—such as microbial biofertilizers, engineered plant traits, and fermentation-derived biopesticides—to enhance crop yields and reduce environmental impact Biotechnology-Based Chemical Market
- Personalized medicine workflows leveraging genomic profiling and CRISPR-based editing to tailor treatments at the molecular level Biotechnology Market Outlook, Size, Share, Trends 2025-33
- Industrial bioprocessing innovations in fermentation and cell-culture systems to produce biofuels, enzymes, and specialty chemicals with improved cost-efficiency and sustainability
Emergent Trends and Core Insights
- Mounting chronic disease prevalence is driving rapid adoption of biologics and diagnostics, with global deaths from cancer, cardiovascular, and respiratory diseases continuing to climb.
- Integration of artificial intelligence and machine learning into R&D pipelines is significantly shortening discovery timelines and improving target validation Startup Series – Tech, genes, and beyond: Transforming Biotech
- Government policies and funding initiatives worldwide—such as India’s BIO-E3 program and U.S. FDA advanced therapies guidance—are catalyzing investment and de-risking novel biotech ventures Biotechnology Market Size to Hit USD 5.71 Trillion by 2034
- Market consolidation around platform providers is intensifying, as companies seek end-to-end solutions spanning discovery, development, and manufacturing.
Technologies and Methodologies
- Recombinant DNA technology, enabling the assembly and expression of novel genetic constructs at scale
- Bioinformatics and data-mining platforms applying ICT for sequence analysis and machine learning in genomics
- High-throughput genomic engineering systems for microbial strain optimization using automation and AI
- Specialized vector systems and host platforms for efficient gene delivery in eukaryotic cells
- Next-generation sequencing combined with machine-learning-driven analysis for rapid, high-resolution biological insights
Biotechnology Funding
A total of 25.0K Biotechnology companies have received funding.
Overall, Biotechnology companies have raised $2.8T.
Companies within the Biotechnology domain have secured capital from 103.7K funding rounds.
The chart shows the funding trendline of Biotechnology companies over the last 5 years
Biotechnology Companies
- SonderBio is developing novel microbial platforms for secreted protein production, enabling scalable manufacturing of biotherapeutics with reduced costs. This under-the-radar firm focuses on optimizing fermentation media and strain engineering to improve yield and product consistency.
- DeepBlueBiotech engineers cyanobacterial chassis for carbon-neutral chemical synthesis, leveraging photosynthesis to convert CO₂ into specialty biochemicals with applications in materials and fuels.
- BioMindz integrates AI-driven predictive modeling with laboratory automation to accelerate lead optimization in small-molecule drug discovery, cutting cycle times by up to 50%.
- Ailurus.bio specializes in biosafety screening services, using high-throughput microbial assays to evaluate environmental and human health impacts of novel biologic products.
- Cosymbio offers precision fermentation solutions for sustainable flavor and fragrance ingredients, partnering with consumer goods brands to replace petrochemical-derived compounds with bio-based alternatives.
Identify and analyze 112.6K innovators and key players in Biotechnology more easily with this feature.
112.6K Biotechnology Companies
Discover Biotechnology Companies, their Funding, Manpower, Revenues, Stages, and much more
Biotechnology Investors
TrendFeedr’s investors tool offers a detailed view of investment activities that align with specific trends and technologies. This tool features comprehensive data on 45.6K Biotechnology investors, funding rounds, and investment trends, providing an overview of market dynamics.
45.6K Biotechnology Investors
Discover Biotechnology Investors, Funding Rounds, Invested Amounts, and Funding Growth
Biotechnology News
Stay informed and ahead of the curve with TrendFeedr’s News feature, which provides access to 174.3K Biotechnology articles. The tool is tailored for professionals seeking to understand the historical trajectory and current momentum of changing market trends.
174.3K Biotechnology News Articles
Discover Latest Biotechnology Articles, News Magnitude, Publication Propagation, Yearly Growth, and Strongest Publications
Executive Summary
Biotechnology is rapidly maturing into a platform-driven industry, where integration of AI, high-throughput engineering, and sustainable biomanufacturing will determine market leadership. Stakeholders must navigate accelerating R&D timelines, evolving regulatory landscapes, and intensifying consolidation to capture value. Those who invest in end-to-end platforms or provide indispensable “ingredient” technologies—whether in gene editing, data analytics, or fermentation optimization—will emerge as critical enablers of the next wave of innovation and growth
Interested in enhancing our coverage of trends and tech? We value insights from experts like you - reach out!
